Toronto Dominion Bank’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-7,355
Closed -$475K – 2379
2026
Q1
$475K Buy
7,355
+7,351
+183,775% +$518K ﹤0.01% 1451
2025
Q4
$274 Hold
4
– – ﹤0.01% 1986
2025
Q3
$328 Hold
4
– – ﹤0.01% 1860
2025
Q2
$195 Hold
4
– – ﹤0.01% 1753
2025
Q1
$266 Buy
4
+2
+100% +$116 ﹤0.01% 1497
2024
Q4
$93 Buy
+2
New +$103 ﹤0.01% 1501
2021
Q4
– Sell
-80
Closed -$3K – 1712
2021
Q3
$3K Buy
+80
New +$3.35K ﹤0.01% 1311

Other funds holding HALO

Toronto Dominion Bank's HALO Position: Q2 2026 in Review

Toronto Dominion Bank sold out of Halozyme (HALO) in Q2 2026, closing a stake of 7,355 shares — an estimated $475K sold.

Toronto Dominion Bank first reported a position in HALO in Q3 2021 and held it in 7 quarters. The position peaked at $475K in Q1 2026. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Toronto Dominion Bank reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 7,355 Halozyme shares in Q2 2026, an estimated $475K.
  • Toronto Dominion Bank first reported a position in Halozyme in Q3 2021 and held it in 7 quarters.
  • Toronto Dominion Bank's Halozyme position peaked at $475K in Q1 2026.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.